Health Condition 1: H409- Unspecified glaucoma
Conditions
Interventions
Intervention1: Trabeculectomy: Trabeculectomy surgery
Control Intervention1: Trabeculectomy: With and without Mitomycin C (for 45 sec with 0.2 % mitomycin C )
Sponsors
PRATIBHA SESAMA
Eligibility
Inclusion criteria
Inclusion criteria: all patients undergoing trabeculectomy
Exclusion criteria
Exclusion criteria: bleb infection patient who did not give consent patient already on antimetabolite therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| trabeculectomy done with mitomycin c rendered good cystic functional outcomeTimepoint: 6 weeks post operative evaluation of bleb through UBM | — |
Secondary
| Measure | Time frame |
|---|---|
| to study the role of mitomycin c in functional status of trabeculectomy blebTimepoint: 6 weeks gap in between surgery and the bleb monitoring | — |
Countries
India
Contacts
Public ContactPRATIBHA SESAMA
UCMS and GTBH
Outcome results
None listed